A Rational approach towards the Management of Benign Breast Diseases (BBD)

Abstract

Benign Breast Diseases (BBD) accounts for the most common cause of breast problems in modem day practices. Up to 30% of women will suffer from a BBD requiring treatment at some time or other in their lives. The important aspect is to differentiate a BBD from a malignant lesion. It is under these circumstances that BBD assumes significance.  

The factors in normal breast development are examined. The risk factors in development of malignancy are discussed.

From our experience spanning over twenty years, we have devised a more practical and cost effective management plan for BBD. This is presented below because nowadays there is an alarming increase in interventional surgeries for BBD for which it is not at all recommended and many of them return to yet another doctor with a history of recurrence and this cycle goes on and on.

When patients present with BBD after confirmation of the benign status of the disease the options are medical management with Danazol or Bromocryptin before surgery. This will reduce the number of patients needing surgery.